The use of antidepressants in Belgian nursing homes: Focus on indications and dosages in the PHEBE study

Drugs and Aging

Volumn 29, Issue 9, 2012, Pages 759-769

  Bourgeois, Jolyce ^a   Elseviers, Monique M ^a,b   Van Bortel, Luc ^a   Petrovic, Mirko ^a,c   Vander Stichele, Robert H ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BELGIUM; CHECKLIST; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DATA BASE; DEPRESSION; DRUG CHOICE; FEMALE; GENERAL PRACTITIONER; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALE; NEUROPATHIC PAIN; NURSING HOME; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RANDOM SAMPLE;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BELGIUM; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DEMENTIA; DEPRESSION; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NURSING HOMES;

EID: 84874608494     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-012-0003-6     Document Type: Article

References (65)

1. Kramer D, Allgaier AK, Fejtkova S, et al. Depression in nursing homes: prevalence, recognition, and treatment. Int J Psychiatry Med. 2009;39(4):345-58.
2. Achterberg W, Pot AM, Kerkstra A, et al. Depressive symptoms in newly admitted nursing home residents. Int J Geriatr Psychiatry. 2006;21(12):1156-62. (Pubitemid 46029219)
3. Brown MN, Lapane KL, Luisi AF. The management of depression in older nursing home residents. J Am Geriatr Soc. 2002;50(1):69-76. (Pubitemid 34053025)
4. Snowdon J, Rosengren D, Daniel F, et al. Australia's use of the Cornell scale to screen for depression in nursing homes. Australas J Ageing. 2011;30(1):33-6.
5. Verkaik R, Francke AL, van Meijel B, et al. Comorbid depression in dementia on psychogeriatric nursing home wards: which symptoms are prominent? Am J Geriatr Psychiatry. 2009;17(7):565-73.
6. Beekman AT, Copeland JR, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry. 1999;174:307-11. (Pubitemid 29179713)
7. Levin CA, Wei W, Akincigil A, et al. Prevalence and treatment of diagnosed depression among elderly nursing home residents in Ohio. J Am Med Dir Assoc. 2007;8(9):585-94. (Pubitemid 350079964)
8. Akincigil A, Olfson M, Walkup JT, et al. Diagnosis and treatment of depression in older community-dwelling adults: 1992-2005. J Am Geriatr Soc. 2011;59(6):1042-51.
9. Gaboda D, Lucas J, Siegel M, et al. No longer undertreated? Depression diagnosis and antidepressant therapy in elderly long-stay nursing home residents, 1999 to 2007. J Am Geriatr Soc. 2011;59(4):673-80.
10. Hanlon JT, Handler SM, Castle NG. Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications. J Am Med Dir Assoc. 2010;11(5):320-4.
11. Fiske A, Wetherell JL, Gatz M. Depression in older adults. Annu Rev Clin Psychol. 2009;5:363-89.
12. Drageset J, Eide GE, Ranhoff AH. Depression is associated with poor functioning in activities of daily living among nursing home residents without cognitive impairment. J Clin Nurs. 2011;20(21-22):3111-8.
13. Hasche LK, Morrow-Howell N, Proctor EK. Quality of life outcomes for depressed and nondepressed older adults in community long-term care. Am J Geriatr Psychiatry. 2010;18(6):544-53.
14. Luppa M, Heinrich S, Matschinger H, et al. Direct costs associated with depression in old age in Germany. J Affect Disord. 2008;105(1-3):195-204. (Pubitemid 350236364)
15. The impact of psychotropics on health with special attention to the elderly. Brussels: Belgium Superior Health Council; 2011 Contract No.: 30.
16. Kane KD, Yochim BP, Lichtenberg PA. Depressive symptoms and cognitive impairment predict all-cause mortality in long-term care residents. Psychol Aging. 2010;25(2):446-52.
17. Karkare SU, Bhattacharjee S, Kamble P, et al. Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am J Geriatr Pharmacother. 2011;9(2):109-19.
18. Hoover DR, Siegel M, Lucas J, et al. Depression in the first year of stay for elderly long-term nursing home residents in the USA. Int Psychogeriatr. 2010;22(7):1161-71.
19. Wilson K, Mottram P, Sivanranthan A, et al. Antidepressant versus placebo for depressed elderly. Cochrane Database Syst Rev. 2001(2):CD000561.
20. Schneider LS, Olin JT. Efficacy of acute treatment for geriatric depression. Int Psychogeriatr. 1995;7(Suppl):7-25.
21. Hollon SD, Jarrett RB, Nierenberg AA, et al. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry. 2005;66(4):455-68. (Pubitemid 40593574)
22. Smith HS, Argoff CE. Pharmacological treatment of diabetic neuropathic pain. Drugs. 2011;71(5):557-89.
23. Wiegand MH. Antidepressants for the treatment of insomnia: a suitable approach? Drugs. 2008;68(17):2411-7.
24. Nishtala PS, McLachlan AJ, Bell JS, et al. Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study. Am J Geriatr Pharmacother. 2009;7(4):210-9.
25. Hanlon JT, Wang X, Castle NG, et al. Potential underuse, overuse, and inappropriate use of antidepressants in older veteran nursing home residents. J Am Geriatr Soc. 2011;59(8):1412-20.
26. Preville M, Vasiliadis HM, Bosse C, et al. Pattern of psychotropic drug use among older adults having a depression or an anxiety disorder: results from the longitudinal ESA study. Can J Psychiatry. 2011;56(6):348-57.
27. Henderson J, Harrison C, Britt H. Indications for antidepressant medication use in Australian general practice patients. Aust N Z J Psychiatry. 2010;44(9):865.
28. Elseviers MM, Vander Stichele RR, Van Bortel L. Drug utilisation in Belgian nursing homes: impact of residents' and institutional characteristics. Pharmacoepidemiol Drug Saf. 2010;19(10):1041-8.
29. Bourgeois J, Elseviers MM, Azermai M, Van Bortel L, Petrovic M, Vander Stichele RR. Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages. Eur J Clin Pharmacol. 2012;68(5):833-44.
30. Azermai M. Elseviers MM, Petrovic M, Van Bortel L, Vander Stichele R. Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum Psychopharmacol. 2011. doi: 10.1002/hup.1160.
31. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-24. (Pubitemid 37517412)
32. Shekelle PG, MacLean CH, Morton SC, et al. Assessing care of vulnerable elders: methods for developing quality indicators. Ann Intern Med. 2001;135(8 Pt 2):647-52. (Pubitemid 33015478)
33. Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176-80. (Pubitemid 36723943)
34. WHO. ATC/DDD system. WHO Collaborating Centre for Drug Statistics Methodology; 2009. http://www.whocc.no/ (Accessed 30 October 2011).
35. Benkert O, Szegedi A, Wetzel H. Minimum effective dose for antidepressants: an obligatory requirement for antidepressant drug evaluation? Int Clin Psychopharmacol. 1996;11(3):177-85. (Pubitemid 26361790)
36. Taylor D, Paton C, Kerwin R. Prescribing guidelines. 10th ed. London: Informa Healthcare; 2010.
37. Dipiro JT, Talbert RL, Matzke GL, Yee GC, Wells BG, Posey ML. Pharmacotherapy: a pathophysiologic approach. 5th ed. New York: McGraw-Hill Medical; 2008.
38. NICE Clinical Guideline 90. Depression: the treatment and management of depression in adults. London: National Institute for Health and Clinical Excellence; 2009. http://www.nice.org.uk/nicemedia/live/12329/45888/45888.pdf (Accessed 10 August 2011).
39. Elseviers MM, Vander Stichele RR, Van Bortel L. Drug utilization in Belgian nursing homes: impact of residents' and institutional characteristics. Pharmacoepidemiol Drug Saf. 2010;19(10):1041-8.
40. Coupland C, Dhiman P, Morriss R, et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551.
41. Kennedy GJ, Marcus P. Use of antidepressants in older patients with co-morbid medical conditions: guidance from studies of depression in somatic illness. Drugs Aging. 2005;22(4):273-87. (Pubitemid 40656017)
42. Petrovic M, De Paepe P, Van Bortel L. Pharmacotherapy of depression in old age. Acta Clin Belg. 2005;60(3):150-6. (Pubitemid 43339170)
43. Movig KL, Leufkens HG, Lenderink AW, et al. Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly. Eur J Clin Pharmacol. 2002;58(2):143-8. (Pubitemid 34507902)
44. Andrade C, Sandarsh S, Chethan KB, et al. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry. 2010;71(12):1565-75.
45. Schellander R, Donnerer J. Antidepressants: clinically relevant drug interactions to be considered. Pharmacology. 2010;86(4):203-15.
46. Draper B, Berman K. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging. 2008;25(6):501-19. (Pubitemid 351812258)
47. Mayers AG, Baldwin DS. Antidepressants and their effect on sleep. Hum Psychopharmacol. 2005;20(8):533-59. (Pubitemid 43056116)
48. Chew ML, Mulsant BH, Pollock BG, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008;56(7):1333-41.
49. Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev. 2006;1:CD003491.
50. Hawton K, Bergen H, Simkin S, et al. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. Br J Psychiatry. 2010;196(5):354-8.
51. Roy AN, Smith M. Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization. Sleep Med. 2010;11(5):462-9.
52. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(2):249-60. (Pubitemid 34038051)
53. Roth AJ, McCall WV, Liguori A. Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs. J Sleep Res. 2011;20:552-8.
54. Conn DK, Madan R. Use of sleep-promoting medications in nursing home residents: risks versus benefits. Drugs Aging. 2006;23(4):271-87. (Pubitemid 43830659)
55. Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-76. (Pubitemid 40593575)
56. James SP, Mendelson WB. The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry. 2004;65(6):752-5.
57. Turnham H. Federal Nursing Home Reform Act from the Omnibus Budget Reconciliation Act of 1987. National Long Term Care Ombudsman Resource Center; 2001. http://www.allhealth.org/briefingmaterials/obra87summary-984.pdf (Accessed 20 October 2011).
58. NICE Clinical Guideline 96: Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. London: National Institute for Health and Clinical Excellence; 2010. http://www.nice.org.uk/nicemedia/live/12948/47949/47949.pdf (Accessed 23 August 2011).
59. B Terluin, K Van der Meer, L Hassink-Franke, F van Heest, J Hekman, H van Marwijk, Mvan Avendonk. Treatment of anxiety (in Dutch: NHG-Standaarden angststoornissen). NHG-Standaarden voor huisartsen: Nederlandse huisartsen genootschap; 2009.
60. NICE Clinical Guideline 113. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. London: National Institute for Health and Clinical Excellence; 2011. http://www.nice.org.uk/nicemedia/live/ 13314/52601/52601.pdf (Accessed 10 August 2011).
61. Treatment of anxiety (in Dutch: de aanpak van angst). Gent: Belgian Centrum for Pharmacotherapeutic Information (BCFI); 2010.
62. Flint AJ. Generalised anxiety disorder in elderly patients: epidemiology, diagnosis and treatment options. Drugs Aging. 2005;22(2):101-14. (Pubitemid 40445321)
63. Margallo-Lana M, Swann A, O'Brien J, et al. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry. 2001;16(1):39-44. (Pubitemid 32111815)
64. Payne JL, Sheppard JM, Steinberg M, et al. Incidence, prevalence, and outcomes of depression in residents of a long-term care facility with dementia. Int J Geriatr Psychiatry. 2002;17(3):247-53. (Pubitemid 34232597)
65. Banerjee S, Hellier J, Dewey M, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011;378(9789):403-11.